Friday, October 31, 2014 2:33:46 PM
Oct 30 2014, 16:06 ET | About: Standard Pacific Corp. (SPF) | By: Mohit Manghnani, SA News Editor
Standard Pacific (NYSE:SPF): Q3 EPS of $0.14 misses by $0.01.
Revenue of $603.8M (+18.1% Y/Y) misses by $19.69M.
Press Release
http://seekingalpha.com/news/2078485-standard-pacific-misses-by-0_01-misses-on-revenue?uprof=45#email_link
Standard Pacific Corp. Reports 2014 Third Quarter Results
Thu October 30, 2014 4:01 PM|PR Newswire | About: SPF
IRVINE, Calif., Oct. 30, 2014 /PRNewswire/ -- Standard Pacific Corp. (NYSE: SPF) today announced results for the third quarter ended September 30, 2014.
2014 Third Quarter Highlights and Comparisons to the 2013 Third Quarter
•Net income of $56.6 million, or $0.14 per diluted share, vs. $58.9 million, or $0.15 per diluted share
•Pretax income of $92.1 million, up 31%
•Net new orders of 1,154, up 4%; Dollar value of net new orders up 11%
•Backlog of 2,208 homes, up 2%; Dollar value of backlog up 17%
•185 average active selling communities, up 10%
•Home sale revenues of $603.8 million, up 18%
•Average selling price of $483 thousand, up 15%
•1,250 new home deliveries, up 3%
•Gross margin from home sales of 26.3%, compared to 25.3%
•Operating margin from home sales of $88.7 million, or 14.7%, compared to $67.4 million, or 13.2%
•$251.2 million of land purchases and development costs, compared to $156.3 million
Scott Stowell, the Company's President and Chief Executive Officer commented, "The solid performance we achieved during the first half of 2014 continued into the third quarter, with pretax income, home sale revenues and backlog value up 31%, 18% and 17%, respectively, over the prior year period." Mr. Stowell added, "In addition, I am pleased with the growth in our operating margin from home sales, which was 14.7% for the 2014 third quarter, compared to 13.2% for the prior year period."
More...
http://seekingalpha.com/pr/11511485-standard-pacific-corp-reports-2014-third-quarter-results
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM